Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 16;19(1):58-62.
doi: 10.1055/s-0043-1771323. eCollection 2024 Mar.

The Accuracy of the S100B Protein Biomarker in the Prognosis of Patients with Acute Spinal Cord Injury

Kaveh Haddadi  1 , Saeed Abediankenari  2 , Saeed Ehteshami  3 , Abbas Alipour  4 , Hassan Shayan Majd  5 , Hamed Jafarpour  5 , Leila Asadian  6
Affiliations

The Accuracy of the S100B Protein Biomarker in the Prognosis of Patients with Acute Spinal Cord Injury

Kaveh Haddadi et al. Asian J Neurosurg. .

Abstract

Introduction The role of some biomarkers such as S100 beta (S100B) has been somewhat known in determining the severity of primary acute spinal cord injury (SCI), and today, it has been the basis of various relevant studies. Therefore, this study estimates the S100B level in serum and cerebrospinal fluid (CSF) in patients with spinal injuries. Methods This was a descriptive-analytic study. In this study, 31 patients with acute SCI referred to Sari Imam Khomeini Hospital, Iran, were recruited. Patients were divided into two groups of complete and incomplete SCI according to the American Spinal Injury Association (ASIA). The S100B concentrations in serum and CSF levels were compared between the two groups. Result There was only significant positive correlation between S100B CSF concentration and complete SCI based on the ASIA criterion, meaning that in cases of complete SCI the S100B CSF concentration was significantly increased correlation coefficient (CC) (cc = 0.529 and p = 0.002). Based on the results of serum S100B protein concentration, 14.70 ng/dL with a sensitivity of 66.7% and specificity of 55% was determined as cutoff for complete SCI. Also, about the CSF S100B protein level variable, concentration of 342.18 ng/dL with 100% sensitivity and 64% specificity was determined as cutoff for complete injury. Conclusion The results of this unique study have shown that S100B were useful markers for predicting the prognosis of patients with acute SCI and cutoff points determined for serum and especially CSF concentrations can differentiate complete and incomplete SCI.

Keywords: S100 beta protein; cerebrospinal fluid; spinal cord injury.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Cutoff point for complete injury based on variable levels of S100B protein in cerebrospinal fluid (CSF) and serum.
See this image and copyright information in PMC

References

    1. van den Berg M E, Castellote J M, Mahillo-Fernandez I, de Pedro-Cuesta J.Incidence of spinal cord injury worldwide: a systematic review Neuroepidemiology 20103403184–192., discussion 192 - PubMed
    1. Rodrigues L F, Moura-Neto V. Biomarkers in spinal cord injury: from prognosis to treatment. Mol Neurobiol. 2018;55(08):6436–6448. - PubMed
    1. WHO Spinal cord injuryNovember 19, 2013.https://www.who.int/news-room/fact-sheets/detail/spinal-cord-injury
    1. Rainey T, Lesko M, Sacho R, Lecky F, Childs C. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point. Resuscitation. 2009;80(03):341–345. - PubMed
    1. Fakharian E, Tabesh H, Masoud S A. An epidemiologic study on spinal injury in Kashan. Gilan Univ J. 2006;13(49):79–85.